FDA Recalls List – September 24, 2014
This article was originally published in The Gray Sheet
The agency’s Sept. 24 enforcement report includes class II recall actions from Fresenius Medical Care, B. Braun Medical and Beckman Coulter.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.